4//SEC Filing
Delaney David 4
Accession 0001209191-22-054100
CIK 0001841330other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:29 PM ET
Size
8.7 KB
Accession
0001209191-22-054100
Insider Transaction Report
Form 4
Delaney David
Other
Transactions
- Purchase
Common Stock
2022-10-17$1.11/sh+1,000$1,110→ 227,521 total(indirect: See footnote)
Concord IP2 Ltd.
Other
Transactions
- Purchase
Common Stock
2022-10-17$1.11/sh+1,000$1,110→ 227,521 total(indirect: See footnote)
Elderhill Corp
Other
Transactions
- Purchase
Common Stock
2022-10-17$1.11/sh+1,000$1,110→ 227,521 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President.
- [F2]191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001943013
Filing Metadata
- Form type
- 4
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:29 PM ET
- Size
- 8.7 KB